SR

Sujatha Rao

Active Director Director DIN 05257812
DIN 05257812 First appointment Apr 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2012
Shareholding value •••• Premium profile

About Sujatha Rao

Data last updated:

Sujatha Rao is a Director at Sancinova Animal Health Private Limited (since 2012). The company operates in Pharma. Sancinova Animal Health Private Limited reported revenue of ₹5.31 Cr (FY 2025).

DIN 05257812
Primary Designation Director
Industry Pharma
First Appointment 18 Apr 2012
Oldest Company Age 14 yrs
Largest company Sancinova Animal Health Private Limited · ₹5.31 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Apr 20122011₹5.31 Cr (FY 2025)Active

Board colleagues of Sujatha Rao

Directorship timeline

Open interactive timeline →
Sancinova Animal Health Private Limited
Premium access

Shareholding and investment profile for Sujatha Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sujatha Rao

Sujatha Rao currently holds 1 directorship: Sancinova Animal Health Private Limited (Director, since 18 Apr 2012, revenue ₹5.31 Cr (FY 2025)).

Sujatha Rao was first appointed on 18 Apr 2012 as Director at Sancinova Animal Health Private Limited.

The current boards of Sujatha Rao's companies include Pandurangarao Manhankali (Sancinova Animal Health Private Limited), Srinivas Thati (Sancinova Animal Health Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available